Abstract
Pregabalin is an anticonvulsant drug that binds to the α2δ (alpha2delta) subunit of the voltage-dependent calcium channel in central nervous system (CNS). Pregabalin decreases the release of neurotransmitters, including glutamate, norepinephrine, substance P and calcitonin gene-related peptide. Purpose of this paper is to offer a qualitative overview of the studies currently available in literature about this drug, examining the effectiveness of pregabalin in its various fields of application. Our analysis, conducted on a final selection of 349 scientific papers, shows that pregabalin may help to reduce pain in diabetic neuropathy, in post-herpetic neuralgia and in some patients affected by fibromyalgia. It is also effective for the treatment of diverse types of seizures and has similar efficacy to benzodiazepines and venlafaxine in anxiety disorder. Moreover, pregabalin may be a therapeutic agent for the treatment of alcohol abuse, in both withdrawal phase and relapse prevention. Possible implications in the treatment of benzodiazepines dependence are emerging, but a potential abuse or misuse of the drug has also been reported. Range of dosage may fluctuate considerably, from 75 mg to 600 mg per day. Further studies are needed to completely understand pregabalin mechanism of action in the different diseases.
Keywords: Abuse, alcohol, anxiety, benzodiazepines, epilepsy, fibromyalgia, neuropathic pain, pregabalin.
Current Pharmaceutical Design
Title:The Potential of Pregabalin in Neurology, Psychiatry and Addiction: A Qualitative Overview
Volume: 19 Issue: 35
Author(s): Giovanni Martinotti, Matteo Lupi, Fabiola Sarchione, Rita Santacroce, Anatolia Salone, Domenico De Berardis, Nicola Serroni, Marilde Cavuto, Maria Signorelli, Eugenio Aguglia, Alessandro Valchera, Felice Iasevoli and Massimo Di Giannantonio
Affiliation:
Keywords: Abuse, alcohol, anxiety, benzodiazepines, epilepsy, fibromyalgia, neuropathic pain, pregabalin.
Abstract: Pregabalin is an anticonvulsant drug that binds to the α2δ (alpha2delta) subunit of the voltage-dependent calcium channel in central nervous system (CNS). Pregabalin decreases the release of neurotransmitters, including glutamate, norepinephrine, substance P and calcitonin gene-related peptide. Purpose of this paper is to offer a qualitative overview of the studies currently available in literature about this drug, examining the effectiveness of pregabalin in its various fields of application. Our analysis, conducted on a final selection of 349 scientific papers, shows that pregabalin may help to reduce pain in diabetic neuropathy, in post-herpetic neuralgia and in some patients affected by fibromyalgia. It is also effective for the treatment of diverse types of seizures and has similar efficacy to benzodiazepines and venlafaxine in anxiety disorder. Moreover, pregabalin may be a therapeutic agent for the treatment of alcohol abuse, in both withdrawal phase and relapse prevention. Possible implications in the treatment of benzodiazepines dependence are emerging, but a potential abuse or misuse of the drug has also been reported. Range of dosage may fluctuate considerably, from 75 mg to 600 mg per day. Further studies are needed to completely understand pregabalin mechanism of action in the different diseases.
Export Options
About this article
Cite this article as:
Martinotti Giovanni, Lupi Matteo, Sarchione Fabiola, Santacroce Rita, Salone Anatolia, Berardis De Domenico, Serroni Nicola, Cavuto Marilde, Signorelli Maria, Aguglia Eugenio, Valchera Alessandro, Iasevoli Felice and Giannantonio Di Massimo, The Potential of Pregabalin in Neurology, Psychiatry and Addiction: A Qualitative Overview, Current Pharmaceutical Design 2013; 19 (35) . https://dx.doi.org/10.2174/13816128113199990425
DOI https://dx.doi.org/10.2174/13816128113199990425 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Renal Function, Albumin-Creatinine Ratio and Pulse Wave Velocity Predict Silent Coronary Artery Disease and Renal Outcome in Type 2 Diabetic and Prediabetic Subjects
Current Hypertension Reviews Pros and Cons of Aggressive Blood Pressure Lowering in Patients with Type 2 Diabetes
Current Vascular Pharmacology Mitochondrial, Metabolic and Genotoxic Effects of Antiretroviral Nucleoside Reverse-Transcriptase Inhibitors
Anti-Infective Agents in Medicinal Chemistry P2X Receptors and Diabetes
Current Medicinal Chemistry Understanding and Avoiding Antiretroviral Adverse Events
Current Pharmaceutical Design Anti-Cancer Compounds Targeted to VDAC: Potential and Perspectives
Current Medicinal Chemistry Flavonoids in the Treatment of Diabetes: Clinical Outcomes and Mechanism to Ameliorate Blood Glucose Levels
Current Diabetes Reviews ADIE - Nursing Interventions of Diabetic Foot Ulcer: An Integrative Review of the Literature
Current Diabetes Reviews Pharmacological Targeting of Neuronal Kv7.2/3 Channels: A Focus on Chemotypes and Receptor Sites
Current Medicinal Chemistry Current Therapeutic Approaches in Inflammatory Bowel Disease
Current Pharmaceutical Design Diabetic Vascular Complications: Pathophysiology, Biochemical Basis and Potential Therapeutic Strategy
Current Pharmaceutical Design Opioids in Neuropathic Pain
Current Pharmaceutical Design Nanofiber Scaffolds for Treatment of Spinal Cord Injury
Current Medicinal Chemistry Experimental Drugs for Neuropathic Pain
Current Neuropharmacology Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders
Current Drug Targets A Guide to Treatment of Sarcoidosis
Current Drug Therapy Connexins, Diabetes and the Metabolic Syndrome
Current Protein & Peptide Science Anti-Inflammatory Activity of Tetracyclines: Applications to Human Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Aldose Reductase: A Novel Target for Cardioprotective Interventions
Current Drug Targets Pharmacological Applications of Antioxidants: Lights and Shadows
Current Drug Targets